Emami Limited Announces Unaudited Standalone Consolidated Earnings Results for the Quarter and Nine Months Ended December 31, 2017; Provides Tax Rate Guidance for the Year
January 29, 2018 at 05:03 am EST
Share
Emami Limited announced unaudited standalone consolidated earnings results for the quarter and nine months ended December 31, 2017. For the quarter on standalone basis, the company reported revenue from operations of INR 7,155.9 million against INR 6,823.3 million a year ago. Earnings before interest, depreciation, amortization and impairment and tax was INR 2,698.2 million against INR 2,675.5 million a year ago. Profit after finance costs but before depreciation, amortization and impairment was INR 2,608.9 million against INR 2,549.5 million a year ago. Profit before tax was INR 1,823.4 million against INR 1,741.8 million a year ago. Profit for the period was INR 1,490.7 million against INR 1,400.7 million a year ago. Cash profit was INR 2,276.2 million against INR 2,208.4 million a year ago. Basic and diluted earnings per share were INR 6.57 against INR 6.17 a year ago.
For the nine months on standalone basis, the company reported revenue from operations of INR 17,937.0 million against INR 18,130.7 million a year ago. Earnings before interest, depreciation, amortization and impairment and tax was INR 5,652.5 million against INR 6,128.3 million a year ago. Profit after finance costs but before depreciation, amortization and impairment was INR 5,384.8 million against INR 5,718.5 million a year ago. Profit before tax was INR 3,125.7 million against INR 3,421.9 million a year ago. Profit for the period was INR 2,593.1 million against INR 2,777.2 million a year ago. Cash profit was INR 4,852.2 million against INR 5,073.8 million a year ago. Basic and diluted earnings per share were INR 11.42 against INR 12.24 a year ago.
For the quarter on consolidated basis, the company reported revenue from operations of INR 7,566.4 million against INR 7,259.5 million a year ago. Earnings before interest, depreciation, amortization and impairment and tax was INR 2,702.0 million against INR 2,667.1 million a year ago. Profit after finance costs but before depreciation, amortization and impairment was INR 2,609.6 million against INR 2,539.9 million a year ago. Profit before tax was INR 1,809.9 million against INR 1,723.3 million a year ago. Profit for the period was INR 1,470.8 million against INR 1,342.4 million a year ago. Profit attributable to owners of the company was INR 1,471.9 million against INR 1,343.4 million a year ago. Cash profit was INR 2,271.6 million against INR 2,160.0 million a year ago. Basic and diluted earnings per share were INR 6.49 against INR 5.92 a year ago.
For the nine months on consolidated basis, the company reported revenue from operations of INR 19,258.6 million against INR 19,548.9 million a year ago. Earnings before interest, depreciation, amortization and impairment and tax was INR 5,635.3 million against INR 6,029.2 million a year ago. Profit after finance costs but before depreciation, amortization and impairment was INR 5,359.8 million against INR 5,617.1 million a year ago. Profit before tax was INR 3,059.3 million against INR 3,294.9 million a year ago. Profit for the period was INR 2,465.7 million against INR 2,567.1 million a year ago. Profit attributable to owners of the company was INR 2,469.1 million against INR 2,571.0 million a year ago. Cash profit was INR 4,769.6 million against INR 4,893.2 million a year ago. Basic and diluted earnings per share were INR 10.88 against INR 11.33 a year ago. Net debt is roughly about INR 2,000 million.
The company expects taxes of 18% to 19% for the current year.
Emami Limited is an India-based company, which is focused on personal and healthcare businesses in India. The Company is engaged in the business of manufacturing health, beauty and personal care products. The Companyâs brands, including BoroPlus, Navratna, Zandu, Fair and Handsome, Kesh King, Mentho plus balm, Dermicool, 7 Oils in One, HE, Diamond Shine, Emami Golden Beauty, Emami Naturally Fair, Emami Emasol and Creme21. It has a portfolio of over 300 + products based on ayurvedic formulations. Its operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe and the CIS countries. It provides Ayurvedic Antiseptic Cream, Prickly Heat Powder, Doodh Kesar Body Lotion, Vasocare Herbal Petroleum Jelly, Aloe Vera Gel, Hygiene Range, Cool Oil, Extra Thanda, Gold Ayurvedic Oil and others. It has manufacturing units in India and abroad to develop products suited to meet the diverse needs and preferences of consumers in different markets.
Emami Limited Announces Unaudited Standalone Consolidated Earnings Results for the Quarter and Nine Months Ended December 31, 2017; Provides Tax Rate Guidance for the Year